Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic betacoronavirus responsible for causing Middle East respiratory syndrome (MERS), a severe viral respiratory illness. It primarily infects humans through direct or indirect contact with dromedary camels. MERS-CoV is an enveloped, positive-sense single-stranded RNA virus. There is no specific antiviral treatment for MERS; management is supportive care. Preventive measures focus on avoiding contact with camels/camel products and practicing good hand hygiene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Middle East Respiratory Syndrome Coronavirus (MERS-CoV).